Ataxia

>

The NeurologyLive® Ataxia Disease Spotlight page provides in-depth updates and specific coverage on the latest data readouts and expert conversations related to the treatment and management of patients with the movement disorder.

Latest News

Researchers to Assess Gene Editing Technology for Friedreich Ataxia Following MDA, FARA Collaboration
Researchers to Assess Gene Editing Technology for Friedreich Ataxia Following MDA, FARA Collaboration

April 20th 2024

The research grant aims to diversify Friedreich ataxia treatments, addressing challenges in trial design and therapeutic strategies for this condition.

Sylvia Boesch, MD, MSc
Prospective Cohort Study Identifies Critical Predictors of Survival in Friedreich Ataxia

March 30th 2024

Dysfunctional Microglia Identified in Friedreich Ataxia, Providing Potential Target to Halt Neurodegeneration
Dysfunctional Microglia Identified in Friedreich Ataxia, Providing Potential Target to Halt Neurodegeneration

March 9th 2024

David Lynch, MD, PhD, neurologist and director of the Friedreich's Ataxia Program at Children's Hospital of Philadelphia
Vatiquinone Treatment Shows Benefit Across End Points for Friedreich Ataxia in Phase 3 MOVE-FA Trial

March 4th 2024

PPD/TFS Fostering Global Awareness in Rare Disorders
PPD/TFS Fostering Global Awareness in Rare Disorders

February 29th 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.